Advances in Tissue & Genetic Engineering for the Treatment of Arthritic Diseases
	The Knowledge Foundation, Inc. , Wyndham Hotel, Boston, MA September 11-12, 2000
	New and exciting concepts are applied to design treatments for arthritic diseases. Speakers from academia and industry will provide their most recent discoveries on: Chondrocyte stimulation by growth factors, Biomechanical aspects and requirements for cartilage repair, New developments on materials and templates, Formation of cartilaginous tissue in vitro, Autologous chondrocyte cell transplantation, Mesenchymal stem cell transplantation and Novel gene delivery strategies. This international conference focuses specifically on state of the art tissue and genetic engineered approaches in the treatment of osteoarthritis and rheumatoid arthritis.
	Organized by:	The Knowledge Foundation, Inc.
	Invited Speakers:	Michael Sittinger, Associate Professor, German Rheumatism Research Center, Berlin and Medical Faculty Charite Berlin, Experimental Rheumatology and Tissue Engineering, Berlin, Germany A. Robin Poole, Ph.D., D.Sc, Director, Joint Diseases Laboratory, Shriners Hospitals for Children, Canadian Hospital; Professor, McGill University, Montreal; Associate Program Director of the Canadian Arthritis Network Wim B. van den Berg, Ph.D., Prof. of Exp. Rheumatology, Nijmegen, The Netherlands Barbara D. Boyan, Ph.D., Professor and Director of Orthopaedic Research, Director of the Center for the Enhancement of the Biology/Biomaterials Interface, University of Texas Health Science Center at San Antonio Farshid Guilak, Ph.D., Assistant Professor and Director of Orthopaedic Research, Duke University Medical Center Peter A. Torzilli, Ph.D., Senior Scientist, Laboratory for Soft Tissue Research, Research Division, Hospital for Special Surgery, New York Alan J. Grodzinsky, Director, MIT Center for Biomedical Engineering; Professor of Electrical, Mechanical, and Bioengineering, Departments of Electrical and Mechanical Engineering, and Division of Bioengineering and Environmental Health, Massachusetts Institute of Technology Robert Sah, M.D., Sc.D., Associate Professor of Bioengineering, Department of Bioengineering, University of California San Diego Shu-Tung Li, Ph.D., President, Collagen Matrix, Inc.; Sr. VP of Research, ReGen Biologics, Inc. Dale P. DeVore, Ph.D.,* Chief Scientific Officer and Senior Vice President of R&D, Collagenesis, Inc. Jennifer Elisseeff, Ph.D., Pharmacology Research Associate Fellow, Craniofacial Developmental Biology and Regeneration Branch, NIDCR, NIH Endre A. Balazs, MD, Chief Executive Officer, Chief Scientific Officer, Biomatrix, Inc. Koichi Masuda, M.D., Associate Professor, Department of Biochemistry and Orthopedic Surgery, Rush Medical College Barbara Huibregtse, DVM, Genzyme Corporation Karl-Gerd Fritsch, M.D., Ph.D.*, Co.don AG Frank Barry, Ph.D. Robert Deans, Vice President Applied Research, Osiris Therapeutics Stephen B. Trippel, M.D., Professor, Department of Orthopaedics, Massachusetts General Hospital and Harvard Medical School Steven C. Ghivizzani, Ph.D.*, Assistant Professor, Center for Molecular Orthopaedics, Harvard Medical School Sakae Tanaka, M.D., Ph.D., Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Japan Vijaykumar Baragi, Senior Research Associate, Inflammation Therapeutics, Parke-Davis
	Deadline for Abstracts:	Poster Abstract Deadline: August 10, 2000
	Registration:	Commercial: $1099 US Academic/Government: $799 US
	Email for Requests and Registration:	custserv@.knowledgefoundation.com
	Posted by: Richard Famiglietti   Host: wks154.knowledgefoundation.com date: May 15, 2000 15:16:21 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.